Global Plasma Fractionation Sales Market Report 2020

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
North America is the largest supplier of Plasma Fractionation, with production revenue market share about 60%, and the sales market share is 44% in 2015. That is to say, there are a large number of exports in North America, while North America also is the largest consumption region.
Europe, following North America, takes production revenue market share of 20% and the sales market share over 20% in 2015. China is an important market of Plasma Fractionation in Asia, accounting for 11% production revenue market share and 12% sales revenue market share of global market in 2015.
Japan has production revenue market share of 5% and sales revenue market share of 7% nearly in 2015. The local production can meet most local demand, and there is a small amount of imports.
Baxter, CSL, Grifols are the leaders of the industry, with 65% market share in 2015, and hold key technologies and patents. Other manufactures’ products are used to meet local demand. With further expanding market, there will be more players in the future.

Market Analysis and Insights: Global Plasma Fractionation Market
The global Plasma Fractionation market size is projected to reach US$ 41910 million by 2026, from US$ 28240 million in 2020, at a CAGR of 6.8% during 2021-2026.

Global Plasma Fractionation Scope and Market Size
The global Plasma Fractionation market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Plasma Fractionation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Plasma Fractionation market is segmented into
Albumin
Immune Globulin
Coagulation Factor
Other

Segment by Application, the Plasma Fractionation market is segmented into
Immunity
Therapy
Other

The Plasma Fractionation market is analysed and market size information is provided by regions (countries). Segment by Application, the Plasma Fractionation market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape

and Plasma Fractionation Market Share Analysis
Plasma Fractionation market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Plasma Fractionation business, the date to enter into the Plasma Fractionation market, Plasma Fractionation product introduction, recent developments, etc.

The major vendors covered:
Shire (Baxalta)
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio